Press Release

Joint Pain Injections Market to Grow with a CAGR of 7.02% through 2028

Changing patient preferences, technological advancements, and increasing awareness are expected to drive the Global Joint Pain Injections Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Joint Pain Injections Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Joint Pain Injections Market stood at USD 4.66 billion in 2022 and is anticipated to grow with a CAGR of 7.02% in the forecast period, 2024-2028. This can be attributed to emerging markets. While North America and Europe have traditionally dominated the joint pain injections market, emerging economies in the Asia-Pacific region are now contributing to its growth. The increasing middle-class population in countries like India and China, along with improving healthcare infrastructure, is expanding the market's reach.

Furthermore, increasing patient education and empowerment is a pivotal trend in the joint pain injections market. Patients are becoming more involved in their healthcare decisions, thanks to the availability of information and support. Educated patients are more likely to consider and opt for joint pain injections, as they understand the benefits and risks associated with these treatments.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Joint Pain Injections Market.”

 

The global market under study was significantly impacted by the COVID-19 pandemic, primarily due to the pandemic-related restrictions affecting the diagnosis and treatment of chronic diseases on a global scale. For instance, a research article titled "COVID-19 and Rheumatoid Arthritis," published in May 2021, highlighted the vulnerability of older patients with rheumatoid arthritis (RA) to COVID-19. The RA patient community experienced disruptions in accessing care, a transition to telemedicine, shortages of essential medications, increased anxiety, and social isolation, all contributing to disease flares. Access to therapy was constrained during the pandemic, with 42% of patients reporting canceled or postponed appointments and a shift to telemedicine visits. Consequently, COVID-19 had an adverse impact on the market for joint pain injections.

Additionally, the market is significantly influenced by the rising prevalence of arthritis and the global increase in the aging population, along with a growing demand for knee pain relief injections. According to the World Population Prospects 2022 report, the percentage of the population aged 65 and over is on the rise, with projections of 3.3% in Sub-Saharan Africa, 7.0% in Northern Africa and Western Asia, 8.1% in Central and Southern Asia, and 22.0% in Europe and Northern America by 2030. Since arthritis is more prevalent among the elderly, the market segment is expected to expand in tandem with the aging population.

Moreover, according to an October 2021 update from the Centers for Disease Control and Prevention, 43% of osteoarthritis patients in 2020 were 65 years of age or older, and the highest annual incidence of knee osteoarthritis occurs between 55 and 64 years of age. More than half of individuals with symptomatic knee osteoarthritis are younger than 65. With the aging population expected to grow, there will likely be an increased burden of osteoarthritis and related conditions, further driving the growth of the studied market throughout the forecast period.

The Global Joint Pain Injections Market is segmented into type of injection, application, regional distribution, and company.

Based on its type of injection, the Hyaluronic Acid Injections sector is poised for growth in the foreseeable future. These injections are employed to alleviate knee pain associated with osteoarthritis (OA) in patients who have already attempted ineffective treatments like acetaminophen and other pain relievers. Hyaluronic acid injections have gained popularity as a non-surgical therapeutic option, particularly due to clinicians' hesitancy to administer repeated corticosteroid injections into the joints.

Market participants are actively engaged in the development of innovative products with numerous advantages, frequently introducing new offerings. For example, in August 2021, Seikagaku Corporation introduced HyLink, a single-injection Visco supplement for intra-articular use in treating knee osteoarthritis in Taiwan through TCM Biotech International Corp. The primary ingredient is a cross-linked hyaluronate hydrogel created using cross-linking technology. These product launches are expected to drive growth in this segment during the forecast period.

Based on application, the Knee & Ankle segment is poised to capture a significant market share in the Global Joint Pain Injections Market during the forecast period for several compelling reasons. Firstly, knee and ankle joints are particularly susceptible to wear and tear, making them more prone to conditions like osteoarthritis and sports-related injuries, driving the demand for pain-relieving injections. Secondly, the rise in the aging population, combined with the growing prevalence of joint-related issues, has increased the patient pool seeking effective non-surgical solutions. Additionally, advancements in injection technologies and the development of specialized products tailored to the specific needs of the knee and ankle joints have made these injections more efficient and accessible. Furthermore, patients and healthcare providers increasingly prefer these injections over surgical interventions, making the Knee & Ankle segment a promising growth area within the Joint Pain Injections Market.

 

Major companies operating in Global Joint Pain Injections Market are:

  • Anika Therapeutics Inc
  • Bioventus LLC
  • Ferring Pharmaceuticals Inc
  • Sanofi SA
  • Pfizer Inc
  • Eli Lilly & Co
  • Flexion Therapeutics Inc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet Holdings, Inc.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The global joint pain injections market is on the cusp of transformative change. As personalized medicine, advanced biologics, telemedicine, AI-driven treatments, and other trends gain momentum, the market is expected to provide more effective, patient-centric solutions for joint pain management. These innovations promise to improve the lives of millions of individuals suffering from joint pain, further fueling the growth of this dynamic and evolving healthcare sector,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Joint Pain Injections Market By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others), By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Joint Pain Injections Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Joint Pain Injections Market.

 

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News